Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 5Heart Diseases 3Carcinoma, Non-Small-Cell Lung 3Vascular Diseases 2Cardiovascular Diseases 2Cardiotoxicity 2Small Cell Lung Carcinoma 1Metabolic Diseases 1Liver Neoplasms 1Hematologic Neoplasms 1Heart Failure 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1Cancer Therapy-related Cardiovascular Toxicity 1

Interventions

atezolizumab 5durvalumab 4Drug Therapy 4Carboplatin 4Psychiatric Rehabilitation 3Immunotherapy 3Topotecan 2Specimen Handling 2Radiotherapy 2Polymerase Chain Reaction 2PM 01183 2Observation 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Ifosfamide 2Etoposide 2Cisplatin 2Biopsy 2trastuzumab deruxtecan 1nedaplatin 1X-Ray Therapy 1Watchful Waiting 1Vinorelbine 1Tomography, Optical Coherence 1Tissue Banks 1Therapeutics 1Radiation, Ionizing 1Phlebotomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Small Cell Lung Carcinoma × Antineoplastic Agents × Clear all
NCT04663438 2020-12-11

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

Peking Union Medical College Hospital

Unknown
300 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡